Main > ONCOLOGY (**) > GIST > Treatment > USA. D. Kinase Inhibitor Tablets>
USA. D. Kinase Inhibitor Tablets>'s subsections
(*) AU Approval Date: 2020. 07.14.
(*) CA Approval Date: 2020. 06.22.
(*) CH Approval Date: 2021. 10.12
(*) EU Approval Date: 2021. 11.22
(*) UK Approval Date: 2021. 12.21
(*) USA Approval Date: 2020. 05.15.
(*) USA Launch Date: 2020. 06.04.
>Prior Treat. >3 Kinase Inhibitors
Company
Generic Name: Ripretinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 10.12.
RTM
RTM Web-Site
USA. D. Kinase Inhibitor Tablets>'s products
This section has no products